References
Liddle G.W., Bledsoe T., Coppage W.S. A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Tr. Assoc. Am. Physic. 76: 199, 1963.
Brown J.J., Ferris J.B., Fraser R. Apparently isolated excess deoxycorticosterone in hypertension: a variant of the mineralocorticoid excess syndrome. Lancet 2: 243, 1972.
Turpie A.G., Thompson T.J. Carbenoxolone sodium in the treatment of gastric ulcer with special reference to its side effects. GUT 6: 591, 1956.
Conn J.W., Rovner D.R., Cohen E.L. Licoriced-induced pseudoaldosteronism. JAMA 205: 492, 1968.
Funder J.V., Adam W.R., Mantero F., Kroft N., Ulick S. The etiology of a syndrome of factitious hypermineralocorticoid excess: a steroid containig spray. J. Clin. Endocrinol. Metab. 41: 842, 1979.
Mantero F., Armanini D., Opocher G., Fallo F., Sampieri L., Cuspidi B., Ambrosi C, Faglia G. Mineralocorticoid hypertension due to a nasal spray containing 9-alfa-fluoroprednisolone. Am. J. Med., 71: 352, 1981.
Gottswinter J.M., Korth-Schütz S., Ziegler R. Gynecomastia caused by estrogen containing hair lotion. J. Endocrinol. Invest. 7: 383, 1984.
Montoliu J., Botey A., Trilla A., Revert L. Pseudoprimary aldosteronism from the topical application of 9-alpha-fluoroprednisolone to the skin. Clin. Nephrol 22: 262, 1984.
Praga M., Maiz E., Mijars R.P., Lopez De Novales E. Pseudoaldosteronism due to 9 alpha fluoroprednisone creams Clin. Nephrol 20: 321, 1983.
Bartorelli A., Rimondini A. Severe hypertension in childhood due to prolonged skin application of a mineralocorticoid ointment. Hypertension 6: 586, 1984.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pedrinelli, R., Lucarini, A., Graziadei, L. et al. Factitious hypermineralocorticoidism due to transdermal application of a 9-alpha-prednisolone containing ointment. J Endocrinol Invest 8, 393–394 (1985). https://doi.org/10.1007/BF03348520
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348520